Der sås også en statistisk signifikant forbedring i forhold til placebo i rasagilin 0, 5 mg gruppen, men forbedringen var mindre.
There was also a statistically significant improvement over placebo with the rasagiline 0.5 mg group, yet the magnitude of improvement was lower.